Biochemical aspirin resistance

The inability of aspirin to produce an anticipated effect on one or more tests of platelet function, such as inhibiting the biosynthesis of thromboxane, inhibiting platelet aggregation, and causing a prolongation of the bleeding time. The rationale for this testing is the concern as to whether aspirin therapy can in a given patient help prevent a heart attack or stroke.